Background {#sec1}
==========

A novel coronavirus was reported as the source of severe viral pneumonia in Wuhan, Hubei Province, China at the end of December 2019 \[[@bib1],[@bib2]\]. Since then, it has spread exponentially, contributing to a pandemic that has led to \>6 million documented cases of coronavirus disease 2019 (COVID-19) reported to the WHO, including \>373 000 deaths as of 1 June 2020 \[[@bib3], [@bib4], [@bib5]\]. We describe the first confirmed fatal case of COVID-19 in Libya.

Case presentation {#sec2}
=================

We report an 86-year-old woman in Libya with no recent travel history. She had a history of type 2 diabetes mellitus and human immunodeficiency virus (HIV) infection for which she reported non-compliance with antiretroviral therapy (zidovudine 300 mg (tablet) every 12 h). On 15 March 2020, she visited a local clinic in Tripoli with a cough and fever after attending a wedding with her family. She was diagnosed with lobar pneumonia and started amoxicillin and clavulanate 875 mg (tablets) every 12 h, prednisone 40 mg (tablets) every 12 h and mucolytic syrup. However, her condition did not improve. On 30 March the patient presented to Tripoli University Hospital Emergency Department with a cough, temperature of 39°C, respiratory rate of 24 breaths/min, pulse of 110 beats/min and blood pressure of 130/80 mmHg. A nasopharyngeal swab and sputum were collected, which were negative for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on real-time RT-PCR at the National Centre for Disease Control in Tripoli. After that, the patient was sent home and advised to continue her treatment.

On 1 April 2020, she presented to Abu-Seta Respiratory Outpatient Clinic because of worsening cough, dyspnoea, headache and fever. However, the patient was referred to Alhadba Alkhadra Hospital by Abu-Seta Respiratory Outpatient Clinic, which refused to admit her because of a shortage of facilities. On admission to the hospital on 1 April 2020, her temperature was 38.5°C, respiratory rate 20 breaths/min, pulse 115 beats/min, blood pressure 100/60 mmHg and oxygen saturation 77% on room air. High-resolution CT showed lung infiltration, collapsed left lung due to underlying lung fibrosis, and ground-glass opacities in both lungs, mostly in the lower zone, with a peripheral subpleural distribution ([Fig. 1](#fig1){ref-type="fig"}). The patient was placed on continuous positive airway pressure in the intensive care unit despite the suspicion of COVID-19 after high-resolution CT.Fig. 1Radiological findings of high-resolution computed tomography showed lung infiltration, collapsed left lung due to underlying lung fibrosis and ground-glass opacities in both lungs, mostly in the lower zone, with a peripheral subpleural distribution.Fig. 1

Complete blood counts were: lymphocyte count 0.40 × 10^9^/L (reference range 1.0 × 10^9^ to 4.0 × 10^9^/L); white blood cell count 10.8 × 10⁹/L; platelet count 98 × 10⁹/L and haemoglobin concentration 13.1 g/dL. Liver function test abnormalities were: alkaline phosphatase 198 U/L (reference range 40--129 U/L); normal alanine aminotransferase 15 U/L (reference range 5--41 U/L) and aspartate aminotransferase 45 U/L (reference range 5--43 U/L). Lactate dehydrogenase test abnormalities peaked on admission day at 1200 U/L (reference range 120--300 U/L); ferritin 484 ng/L (reference range 30--400 ng/L) and glucose 182 mg/dL (reference range 70--120 mg/dL). C-reactive protein concentration was 532.2 mg/L (reference range \<5 mg/L).

On 1 April 2020, the patient\'s status deteriorated and she was diagnosed with acute kidney injury, with a urea level of 240 mg/dL (reference range 5--50 mg/dL) and creatinine level of 7.69 mg/dL (reference range 0.4--1.3 mg/dL). The patient was referred for dialysis at Tripoli University Hospital on 2 April. However, she died, despite attempted resuscitation, due to multiple organ dysfunction syndrome following acute kidney injury. A nasopharyngeal swab and sputum were collected, which were positive for SARS-CoV-2 on real-time RT-PCR by the National Centre for Disease Control in Tripoli. However, her family members and health-care workers who managed the patient all tested negative for SARS-CoV-2 on RT-PCR. This case raises questions about SARS-CoV-2 transmission and testing capability in Libya.

Discussion and conclusions {#sec3}
==========================

Testing for SARS-CoV-2 as reported here is mandatory in any situation to avoid exposing care providers. This needs an important investment in testing capability. Civil war and fragility of the health-care system are ongoing challenges to Libya\'s ability to manage and control COVID-19. Therefore, a surveillance plan is needed in Libya to increase the capacity of the government to detect cases of COVID-19, as the National Centre for Disease Control in Tripoli has a low daily capacity to perform SARS-CoV-2 testing, with a mean daily testing capability of \<50 test per day during March and April 2020 \[[@bib6]\]. This case also provides an insight into the importance of co-infection between HIV and SARS-CoV-2. Immunocompromised patients may be at higher risk of complications and deterioration due to COVID-19 infection. Finally, physicians in charge of such patients should be aware that antiretroviral therapy for HIV-positive individuals does not seem to prevent COVID-19, especially those on lopinavir-ritonavir \[[@bib7]\]. Also, we should emphasize that relying on PCR for diagnosis carries the risk of delaying treatment and management of suspected cases of COVID-19. This case provides an insight into the importance of testing for SARS-CoV-2, in the context of an epidemic, all patients with atypical presentations particularly those with associated HIV infection.
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